NTRK2 and diabetic retinopathy: The data also suggested that treatment with 7,8-DHF may have clinical importance in other retinal vascular diseases including diabetic retinopathy and associated macular edema in retinal vein occlusions, based on its ability to activate TrkB and inhibit VEGFR2 receptors at the same time.